Larimar Therapeutics Inc (LRMR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.54 +0.03 (+1.20%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.54 unch (unch) 16:13 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | LRMR | ZTS | TAK | SMMT | UTHR |
| Company | Larimar Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Summit Therapeu ADR | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 2.47 | 162.88 | 15.05 | 19.44 | 311.18 |
| High | 2.56 | 163.04 | 15.31 | 20.02 | 315.69 |
| Low | 2.44 | 160.91 | 15.05 | 19.13 | 308.43 |
| Last | 2.54 | 163.03 | 15.19 | 19.75 | 312.99 |
| Change | +0.03 | -0.13 | +0.03 | +0.31 | -0.61 |
| % Change | +1.20% | -0.08% | +0.20% | +1.59% | -0.19% |
| Volume | 655,300 | 2,886,900 | 2,903,000 | 3,299,600 | 1,155,300 |
| 20-Day Average Volume | 679,905 | 2,847,725 | 1,662,045 | 2,790,480 | 662,395 |
| Previous Close | 2.51 | 163.16 | 15.16 | 19.44 | 313.60 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 165.74 | 14.86 | 19.23 | 317.80 |
| 20-Day Raw Stochastic | 26.88% | 25.29% | 91.19% | 51.95% | 20.56% |
| 20-Day Relative Strength | 37.70% | 46.07% | 68.88% | 49.88% | 40.85% |
| Weighted Alpha | -69.81 | -6.63 | +11.07 | +8.74 | +15.92 |
| Today's Opinion | 100% Sell | 100% Sell | 72% Buy | 40% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 100% Sell | 72% Buy | 24% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 88% Sell | 8% Sell | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.93% since 03/14/25 | +1.10% since 03/14/25 | +1.20% since 03/14/25 | -5.00% since 03/14/25 | +1.87% since 03/14/25 |
| Low | 2.29 on 03/18/25 | 160.91 on 03/21/25 | 15.01 on 03/19/25 | 19.13 on 03/21/25 | 304.55 on 03/17/25 |
| High | 2.64 on 03/17/25 | 165.82 on 03/17/25 | 15.31 on 03/21/25 | 20.85 on 03/17/25 | 324.57 on 03/18/25 |
| 1-Month | |||||
| %Chg | -20.38% since 02/21/25 | +1.60% since 02/21/25 | +8.04% since 02/21/25 | -10.71% since 02/21/25 | -13.32% since 02/21/25 |
| Low | 2.29 on 03/18/25 | 158.30 on 03/14/25 | 14.00 on 02/24/25 | 16.55 on 03/10/25 | 299.47 on 03/13/25 |
| High | 3.22 on 02/24/25 | 177.00 on 03/10/25 | 15.31 on 03/21/25 | 22.71 on 02/24/25 | 365.21 on 02/24/25 |
| 3-Month | |||||
| %Chg | -36.66% since 12/20/24 | -1.10% since 12/20/24 | +15.95% since 12/20/24 | +10.52% since 12/20/24 | -12.96% since 12/20/24 |
| Low | 2.29 on 03/18/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
| High | 4.27 on 01/03/25 | 177.40 on 02/06/25 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 383.51 on 02/19/25 |
| 6-Month | |||||
| %Chg | -64.07% since 09/20/24 | -15.37% since 09/20/24 | +2.64% since 09/20/24 | -19.02% since 09/20/24 | -11.33% since 09/20/24 |
| Low | 2.29 on 03/18/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
| High | 9.50 on 11/11/24 | 197.51 on 09/27/24 | 15.31 on 03/21/25 | 25.50 on 09/23/24 | 417.82 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 162,070 | 73,003,528 | 48,333,044 | 14,569,180 | 14,057,004 |
| Shares Outstanding, K | 63,807 | 447,792 | 3,181,899 | 737,680 | 44,912 |
| Annual Sales | 0 | 9,256,000,000 | 29,419,960,000 | 0 | 2,877,400,000 |
| Annual Net Income | -36,950,000 | 2,486,000,000 | 994,060,000 | -221,320,000 | 1,195,100,000 |
| Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 0 | 735,900,000 |
| Last Quarter Net Income | -15,500,000 | 581,000,000 | 156,180,000 | -61,200,000 | 301,300,000 |
| 60-Month Beta | 0.99 | 0.94 | 0.46 | -1.04 | 0.64 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 10/30/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | -0.08 on 02/24/25 | 6.19 on 02/26/25 |
| Latest Earnings Date | 03/27/25 | 05/01/25 | 05/08/25 | 05/07/25 | 05/07/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.56 | 10.68 | 0.00 | 12.75 |